申请人:GLAXOSMITHKLINE IP DEV LTD
公开号:WO2018029097A1
公开(公告)日:2018-02-15
The present invention relates to a method for synthesising amides that is of general applicability. The method may be performed in vitro or in vivo. Cell lines for use in the in vivo methods also form aspects of the invention. The method for synthesising a non-natural amide comprises: a. reaction of a carboxylic acid with a naturally occurring CoA ligase or a variant thereof; and b. reaction of the product of step a with an amine in the presence of a naturally occurring acyltransferase or a variant thereof; with the proviso that where the CoA ligase and acyltransferase are both naturally occurring, they are not derived from the same source species and do not act sequentially in a metabolic pathway; and with the proviso that the non-natural product is not N-(E)-p-coumaroyl-3-hydroxyanthranilic acid or N-(E)-p-caffeoyl-3-hydroxyanthranilic acid. Further, a method for producing an active pharmaceutical ingredient by the aforementioned method and host cells for carrying out said methods are envisaged.
本发明涉及一种合成酰胺的方法,具有普遍适用性。该方法可以在体外或体内进行。用于体内方法的细胞系也构成本发明的方面之一。合成非天然酰胺的方法包括:a. 将羧酸与天然存在的辅酶A连接酶或其变体反应;b. 在天然存在的酰基转移酶或其变体存在下,将步骤a的产物与胺反应;但辅酶A连接酶和酰基转移酶若均为天然存在,则不能来自相同源物种且不能在代谢途径中依次作用;并且非天然产物不是N-(E)-对香豆酰-3-羟基蒽醌酸或N-(E)-对咖啡酰-3-羟基蒽醌酸。此外,还可以通过上述方法生产活性药物成分的方法和用于执行该方法的宿主细胞。